Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uncovering the metabolomic fingerprint of breast cancer.
Oakman C, Tenori L, Biganzoli L, Santarpia L, Cappadona S, Luchinat C, Di Leo A. Oakman C, et al. Among authors: cappadona s. Int J Biochem Cell Biol. 2011 Jul;43(7):1010-20. doi: 10.1016/j.biocel.2010.05.001. Epub 2010 May 10. Int J Biochem Cell Biol. 2011. PMID: 20460168 Review.
Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods.
Oakman C, Tenori L, Claudino WM, Cappadona S, Nepi S, Battaglia A, Bernini P, Zafarana E, Saccenti E, Fornier M, Morris PG, Biganzoli L, Luchinat C, Bertini I, Di Leo A. Oakman C, et al. Among authors: cappadona s. Ann Oncol. 2011 Jun;22(6):1295-1301. doi: 10.1093/annonc/mdq606. Epub 2011 Jan 3. Ann Oncol. 2011. PMID: 21199886 Free article.
Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?
Biganzoli L, Boni L, Becheri D, Zafarana E, Biagioni C, Cappadona S, Bianchini E, Oakman C, Magnolfi SU, Di Leo A, Mottino G. Biganzoli L, et al. Among authors: cappadona s. Ann Oncol. 2013 Feb;24(2):494-500. doi: 10.1093/annonc/mds331. Epub 2012 Oct 7. Ann Oncol. 2013. PMID: 23045516 Free article.
Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.
Tenori L, Oakman C, Morris PG, Gralka E, Turner N, Cappadona S, Fornier M, Hudis C, Norton L, Luchinat C, Di Leo A. Tenori L, et al. Among authors: cappadona s. Mol Oncol. 2015 Jan;9(1):128-39. doi: 10.1016/j.molonc.2014.07.012. Epub 2014 Aug 10. Mol Oncol. 2015. PMID: 25151299 Free PMC article. Clinical Trial.
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Galardi F, De Luca F, Biagioni C, Migliaccio I, Curigliano G, Minisini AM, Bonechi M, Moretti E, Risi E, McCartney A, Benelli M, Romagnoli D, Cappadona S, Gabellini S, Guarducci C, Conti V, Biganzoli L, Di Leo A, Malorni L. Galardi F, et al. Among authors: cappadona s. Breast Cancer Res. 2021 Mar 24;23(1):38. doi: 10.1186/s13058-021-01415-w. Breast Cancer Res. 2021. PMID: 33761970 Free PMC article. Clinical Trial.
Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients.
Risi E, Lisanti C, Vignoli A, Biagioni C, Paderi A, Cappadona S, Monte FD, Moretti E, Sanna G, Livraghi L, Malorni L, Benelli M, Puglisi F, Luchinat C, Tenori L, Biganzoli L. Risi E, et al. Among authors: cappadona s. Transl Oncol. 2023 Jan;27:101585. doi: 10.1016/j.tranon.2022.101585. Epub 2022 Nov 17. Transl Oncol. 2023. PMID: 36403505 Free PMC article.
22 results